In contrast, miR-944 promotes the corresponding cancer cell proliferation by targeting three genes (SOCS4 [21], CADM2 [22], and HECW2 [25]) and participating in the LINC00899/miR-944/ESR1signaling axis [23]. The gene discussed is CADM2; the disease is cancer.